The regulation of cholesterol metabolism by TRPV1, TRPA1, and TRPC5 through distinct signal pathways can impact lipid accumulation in cells, foam cell formation, and lipid deposition in liver tissue, thereby contributing to the development of AS and NAFLD. This evidence concerns the gene TRPC5 and metabolic dysfunction-associated steatotic liver disease.